CAREGIVER: A Trial to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis

  • End date
    Dec 3, 2022
  • participants needed
  • sponsor
    University of Michigan
Updated on 3 June 2021


The goal of this study is to enroll caretakers of patients with decompensated cirrhosis to determine if written emotional disclosure or resilience training interventions reduce distress and burden among primary informal caregivers.

Caretakers that meet eligibility will complete baseline assessments in person, or if necessary, over the phone and be randomized to be in one of three arms of this study. Materials specific to each study arm will be mailed to the caretakers home along with instructions. Overall, the study will take approximately 2 months and a qualitative interview will also be completed around 3-6 months post-baseline.

Condition Caregiver
Treatment No Treatment, Written emotional disclosure, Resilience training
Clinical Study IdentifierNCT04205396
SponsorUniversity of Michigan
Last Modified on3 June 2021


Yes No Not Sure

Inclusion Criteria

Primary informal caregiver for a patient with a clinical diagnosis of decompensated cirrhosis with either of the following three clinical criteria
Child-Turcotte Pugh (CTP) Class A/B/C cirrhosis with an all cause hospitalization within the previous 30 days
CTP Class B or C cirrhosis with one of the following within the prior 6 months from the date of enrollment
Ascites (requiring paracentesis or diuretics)
Overt Hepatic Encephalopathy (requiring lactulose or rifaximin/flagyl/neomycin)
Spontaneous Bacterial Peritonitis (SBP)
Hepatic Hydrothorax (requiring diuretics or thoracentesis)
Variceal Bleed (with 1 or more recurrences)
Hepatocellular Carcinoma (HCC)
Any Barcelona Clinic Liver Cancer (BCLC) Stage with CTP Class B or C
BCLC Stage C or D with CTP Class A

Exclusion Criteria

Non-English speaking
Unable or unwilling to provide verbal consent
Severe cognitive impairment
Caregiver is participating in another interventional study
Caregiver has used a personal diary within the past 12 months
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note